Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Corlieve Therapeutics logo — At Corlieve, we are focused on bringing novel therapeutic op...

Corlieve Therapeutics

At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders.

Founded 2019 France France 1 employees Seed Biotechnology, Health Care

General Information

Company Name Corlieve Therapeutics
Founded Year 2019
Location France France
Employees 1
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Corlieve Therapeutics. To contact Corlieve Therapeutics, visit corlieve.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Corlieve Therapeutics compare?

A PDF of Corlieve Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Corlieve Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Corlieve Therapeutics

Corlieve Therapeutics is a biotechnology company, established in 2019 in France. As a fully owned subsidiary of UniQure, the company is dedicated to offering innovative treatment options for individuals grappling with severe neurological conditions. The recent milestone for Corlieve Therapeutics was the Seed Round investment on 02 November 2020, which was facilitated by prominent investors including IDInvest Partners, Kurma Partners, Kinled Holding Ltd, and Pureos Bioventures. The company's focus on addressing critical unmet needs in the field of neurological disorders is echoed in their slogan, "At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders." This strategic objective aligns with the growing demand for innovative solutions in the Health Care sector. Corlieve Therapeutics' position as a subsidiary of UniQure also adds to its credibility, benefitting from the expertise and resources of an established biotechnology company. This recent investment indicates a vote of confidence from major players in the investment landscape and underlines the potential for Corlieve Therapeutics to make significant strides in the biotechnology industry.

Business keywords: Neurological Disorders, Therapeutics, Drug Development, Clinical Research, Gene Therapy, Neuroscience, Innovative Medicine, Biopharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 4
IDInvest Partners Kurma Partners Kinled Holding Ltd
IDInvest Partners, Kurma Partners +2
02 Nov 2020

Latest News

View All
Kurma Partners raises €140 million first close of new €250 million Biofund IV — Eu-startups
Kurma Partners raises €140 million first close of new €250 million Biofund IV
Eu-startups Oct 03, 2024

Corlieve Therapeutics Alternatives & Competitors

View All Alternatives
Corlieve Therapeutics vs
RogCon, Inc.
RogCon, Inc. United States

The SCN2A Company

7 employees
Biotechnology, Health Care
Corlieve Therapeutics vs
Mersana Therapeutics
Mersana Therapeutics United States

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fi...

Acquired
159 employees
Biotechnology, Health Care
Corlieve Therapeutics vs
Onconova Therapeutics
Onconova Therapeutics United States

Onconova is focused on discovering and developing novel products for patients with cancer.

Post-IPO Equity
20 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Corlieve Therapeutics

At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders.
Corlieve Therapeutics was founded in 2019.
Corlieve Therapeutics is headquartered in France.
Corlieve Therapeutics operates in Biotechnology and Health Care. Its work centres on Neurological Disorders, Therapeutics, Drug Development and Clinical Research.
Corlieve Therapeutics has approximately 1 employees.
Corlieve Therapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Corlieve Therapeutics include RogCon, Inc., Mersana Therapeutics, Onconova Therapeutics, Xenon Pharmaceuticals Inc., Expansion Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Corlieve Therapeutics and RogCon, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Corlieve Therapeutics, https://bouncewatch.com/company/corlieve-therapeutics, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes